IB1001 (INN: Levacetylleucine) clinical trials

A study in healthy volunteers to assess how the test medicine (IB1001) affects how the body takes up Digoxin and Rosuvastatin (Part 1) and how food affects blood levels of IB1001 (Part 2)

This study looks at a new medicine, IB1001, for rare brain disorders. We want to see how it interacts with other common medicines and how food affects it in healthy people. It's an early-stage study to check safety and how the body handles the medicine.